CRA Insights

The rise of drug prices: What will US payers do next?

April 24, 2015

Lev Gerlovin, Ezra Josephson | Life Sciences
Lev Gerlovin explores the future of payer response to rising drug prices and discuss strategies that manufacturers may consider to gain a competitive edge in this evolving landscape.

Related capabilities

Key contacts